Steve,
I'm looking for info on this as well. I heard about it from probably the same source as you...Kostech Small Cap Research. That article is posted below.
If I find any other info, I'll post it here!
Star.
Kostech Research Bulletin for 11-06-96
Pioneer Services Inc. (OTC:BB:PSVC) is an early stage biotechnology
company which acquired Jacobson Resonance Machines Inc. (JRM) in the early part of July this year. JRM is a Biotech company that has
done extensive studies in the treatment of pain, neurological disorders
(i.e. Parkinson's Disease, Multiple Sclerosis and Epileptic Seizures)
Systemic Diseases, Genetic Diseases, Neoplastic Diseases, Viral
Diseases and Degenerative Diseases. During the past 15 years, the
company has developed and patented an electromagnetic machine that centers around an equation (mc2 = Bvlq) known as Jacobson Resonance. This equation is the key variable in treating the previously mentioned diseases with electromagnetic fields. A number of successful studies have already been done in treating these diseases along with advancements in the areas of Cancer and AIDS.
The Company has a number of attractive factors, but the one that
deserves the most merit is that of credibility. Some of this
credibility was achieved through the efforts of U.S. Senate Majority
Leader Trent Lott. It was his doing that opened the doors for PSVC
to enter in, and establish itself, with the Mississippi Enterprise
for Technology at Stennis Space Center ( a division of NASA ).
This is a very significant alliance in that it enables the two
to collaborate expertise in the development and manufacturing of
electro-magnetic therapy devices that will be based around the
Jacobson Resonance theory. Stennis has agreed to manufacture the
machine, which should start taking place by the end of the week..
The Company is also currently establishing collaborations with a
number of different major Universities across the United States.
One of the most recent was with Dr. Brij Saxena at Cornell Medical
Center, a professor of Endocrinology. With Dr. Jacobson's
expertise in Electro Magnetic Resonance Therapy (EMRT) and Dr.
Saxena, a world renowned scientist, they will be able to combine
their fields of expertise and focus on research to determine
the effects that Jacobson Resonance has on the regeneration of nerve cells involved in neuro-endocrine regulation. It is the management's intent that the research at Cornell will lead to double blind studies in the United States for treating Central-Nervous System Disorders using machines currently being developed by Pioneer. Other such collaborations with other, well acclaimed, universities are
currently being taken into consideration.
By bringing Stennis and Dr. Sexena to the PSVC team, the Company
has achieved two significant goals. First, it has proven the credibility of their research and products. Secondly, they are able to utilize existing laboratories and equipment that will cut down the costs of developing and manufacturing. In addition, any costs that are incurred in the future will in large part be absorbed by the other research teams and companies. This will have a very positive effect on PSVC's bottom line. This type of synergy is expected to continue
as other partners join in.
The machine itself comes in a number of different forms, which
cover a wide array of applications. The smaller version is about
the size of a laptop with a cost of around $1600.00. The larger
version which works like a spa has a cost of around $10,000.00.
With this kind of range, a large market is covered from chiropractors and independent physicians, to major hospitals. This type of treatment is also covered under most insurance policies.
The machine is currently being prepared for the FDA review process
in order to be approved for sale in the U.S., the first up-graded
prototype was completed last weekend. Historically, non-intrusive
devices make it through the process much quicker than other types
of devices. In the interim, the Company will be able to generate
revenues through the opening of treatment facilities abroad. One
such country that is actively being sought after is Mexico. This
could be an extremely valuable step in the process of creating
a revenue stream. Talks to this effect are expected to begin in
the next couple of weeks. Other contracts in different foreign
markets are expected to be pursued followed by the U.S. once FDA
approval has been granted.
This company has several things in the works which will be
unfolding shortly. One of the things that is expected to take
place is the addition of several key members to their board.
One such member that desires to come aboard is Dr. Bjorn E. W.
Nordenstrom, a world renowned scientist whose credentials include
being a member of the Noble Assembly of Medicine for 19 years,
one of which he served as president.
PSVC last traded at 2 1/2
Paid subscribers will receive further updates on this company as events occur.
To gain further insight into this process and the company please
contact: AIM Corporate Relations Inc. toll free at
1-888-948-1227 Dawn Vanzant
1-888-948-8632 Heidi Hirst or email hhirst@direct.ca
Also look at the companies website at:
pw1.netcom.com
Kostech SmallCap Research
kostech.com
COPYRIGHT (c) 1996 by Kostech SmallCap Research. ALL RIGHTS
RESERVED. While it is our intent to research and locate companies
which will provide profitable investments, we are not liable for
any investment decisions by our subscribers. Past performance of
previously featured companies does not guarantee the future
success of a currently featured company. Contact the featured
company and seek advice from your stock broker before reaching
any investment decision. |
